top of page

Late Breaking Abstracts

The Scientific Planning Committee seeks to offer a balanced, diverse, and cutting-edge scientific program that reflects different areas of science from all members of the pain community.  Your participation is of the utmost importance and will be integral for the success of the 2023 Annual Scientific Meeting and continued progress in pain research and management.  All abstracts must be submitted through the CPS abstract submission portal below before Tuesday February 28th by 2259h ET

April 27-30, 2024 at the Westin in Ottawa.

Individuals with an interest in pain from all around the world come together to share knowledge and expertise on the latest advancements in pain mechanisms, evaluation, and management.


Our Accreditation Statement

Hotel and Banff Information
Our Conference Hub

Welcome to the 2024 Annual Scientific Meeting

  • Instagram_Canadian Pain Society
  • Facebook_Canadian Pain Society
  • LinkedIn_Canadian Pain Society
  • X

✶ Plenary Speaker

Dr. Cornelia (Nel) Wieman

Acting CMO for the First Nations Health Authority, British Columbia.

She is Anishinaabe (Mishi-Baawitigong First Nation, Treaty 5 Territory) and lives, works and plays on the unceded territory of the Coast Salish peoples – the səl̓ílwətaʔɬ (Tsleil-Waututh), Sḵwx̱wú7mesh (Squamish), and xʷməθkʷəy̓əm (Musqueam) Nations. She completed her medical degree and psychiatry specialty training at McMaster University. Canada's first female Indigenous psychiatrist, Dr. Wieman has more than 20 years and clinical experience, working with Indigenous people in both rural/reserve and urban settings. Dr. Wieman served as the President of the Indigenous Physicians Association of Canada (IPAC) from 2016 - 2022.

Fibromyalgia: Attempts at Uncovering the Pathophysiology

0820h — Thursday, May 11

Van Horne Ballroom in the Conference Centre

✶ Plenary Speaker

Dr. Michael Salter

Senior Scientist and Emeritus Chief of Research at The Hospital for Sick Children, Toronto.

A Senior Scientist and Emeritus Chief of Research at The Hospital for Sick Children, and Professor in the Department of Physiology at the University of Toronto. He received his MD at the University of Western Ontario and his PhD from McGill University. Professor Salter is determining fundamental molecular and cellular mechanisms of normal and pathological neuroplasticity. His discoveries have broad implications for the control of cell-cell communication throughout the nervous system. He is using his discoveries to design and develop molecules that target major cell signalling pathways in neurons and in glial cells involved in pain, stroke, neurodegenerative diseases and schizophrenia. He has won numerous awards for his work, including being named an International Research Scholar of the Howard Hughes Medical Institute, and a Fellow of the Royal Society of Canada.

Neuroimmune Interactions for the Induction and Resolution of Pain

0815h — Friday, May 12

Van Horne Ballroom in the Conference Centre

Our Plenaries

What's Happening Now

Breakfast and Registration

Friday 0700 — 0800h
Van Horne Ballroom in the Conference Centre

Start your morning off with a well-balanced breakfast.

Opening Remarks

0800 — 0820h
Van Horne Ballroom in the Conference Centre

Canadian Pain Society President Dr. John Pereira, SPC Chairs Dr. Mike Hildebrand & Dr. Gabrielle Page.

Neuroimmune Interactions for the Induction and Resolution of Pain

Friday 0815 — 0915h
Van Horne Ballroom in the Conference Centre.

✭ Our Plenary, Dr. Ru-Rong Ji.

Concurrent Session Four

0925 — 1040h
Mezzanine Level II in the Castle.

‣ The Role of the Gut Microbiome in Somatosensation and Pain - Mechanisms and Clinical Implications.
‣ Pain Experiences of Youth with Neurodevelopmental Disabilities (NDDs): Bridging Research and Practice.
‣ Hot Topics Trainee Presentations.
‣ The Intersection of Pain and Addiction: Using Harm Reduction Strategies to Keep Patients with Chronic Pain Safe Within the Context of the Current Opioid Crisis.

Refreshment Break

Friday 1045 — 1115h
Van Horne Ballroom in the Conference Centre.

Browse posters and connect with our exhibitors.

Concurrent Session Five

Friday 1045 — 1200h
Mezzanine Level II in the Castle.

‣ Can Clinical Trials Translate Pain Science into Improved Care for People Suffering from Pain? Incorporating Basic Principles with Patient Engagement and Real-world Clinical Practice.
‣ Exploring and Healing Pediatric Chronic Pain in Indigenous Youth and Families Through Two-Eyed Seeing.
‣ Pain and Time.
‣ Neurophysiological Changes Following Physical or Emotional Childhood Trauma in the Transition from Acute to Chronic Pain.

A comprehensive summary of the scopes, methods, results, and conclusions of all our approved poster presentations.

Poster Presentations

A deep dive into the abstracts of our keynote, plenaries, and many distinguished speakers presenting during our Seven (7) concurrent sessions.


Our 2023 Art Awards

Our 2024 Art Awards

The Canadian Pain Society Art Awards were created to engage a broad audience and contribute to knowledge mobilization and develop new tools for teaching and communicating about pain and its impact on social life. With a new theme each year, we showcase the variety of artwork presented by clinicians, scientists, educators, artists, and people living with pain.




Focus on Migraine



Presidents Gala



Featured Events

Thank you for taking the time to complete this evaluation. The information collected is extremely valuable and will assist in the planning of future meetings.

Annual Scientific Meeting Event Evaluation

Thank you for reflecting and providing feedback on the symposia session you have just attended.  As a reminder, you must submit an evaluation for each session and cannot evaluate multiple sessions at the same time.

Individual Concurrent Session Evaluation

Our Complete 2024 Agenda

You will gain the ability to describe and critically analyze recent research on the mechanisms and management of pain with our diverse, multidisciplinary membership. You'll integrate activities and understanding that will help improve access to high-quality pain care, including preventing and treating pain more effectively. 


Concurrent sessions have been coordinated to encompass mechanisms of pain; biopsychosocial factors of pain; pain treatments; and pain programs, education, policy, and advocacy.

All efforts will be in place to avoid any timing adjustments, that may occur without advance notice. All timing for this event is in Mountain Daylight Time. 


View speaker Conflicts of Interest.

Filter by Filter



Inflammatory Arthritis and Disease Modifying Agents: What Pain Management Practitioners Need to Know

Speaker: M. Stein

Patients who suffer from inflammatory rheumatic diseases often experience pain. It is important to identify these patients in part to establish a diagnosis but also to recognize that rheumatic conditions are associated with damage to different organs which may influence investigations and choice of therapy. Furthermore, it is important for clinicians who treat patients with pain syndromes to become familiar with medications used in the treatment of inflammatory arthritis. LEARNING OBJECTIVES 一 Recognize the signs and symptoms of inflammatory arthritis. 一 Increase awareness of undiagnosed and active rheumatic diseases in patients with chronic pain. 一 Familiarize themselves with common disease modifying medications used for rheumatic diseases.


From a gap in care to real-world solutions: Steps to reduce the burden of chronic postsurgical pain in Alberta.

Speakers: K. Denness, T. Wasylak, B. Rosenbloom

Preventing the transition from acute to chronic pain is a top priority for patients and families, healthcare professionals, and policy makers across Canada. Prevention of chronic postsurgical pain (CPSP) is aligned with the vision and guiding principles of the Alberta Pain Strategy, a document that outlines collaborative and coordinated efforts to assess, treat, and manage pain across Alberta. In this session, we offer examples of initiatives underway to reduce the burden of CPSP, from the broad systems-level activities of the Alberta Pain Strategy to patient-centered approaches offered before surgery, during acute care, and after hospital discharge. Initiatives include codeveloping screening measures, leveraging the provincial clinical information system to optimize analgesic prescribing, creating a series of learning modules for acute care nurses, implementing a patient-facing digital tool, and laying foundations for a virtual surgical transitional pain service. LEARNING OBJECTIVES 一 Explore the evolution of the Alberta Pain Strategy as a comprehensive approach to helping Albertans manage pain across their lifespan. 一 Explain key elements in the design and implementation of evidence-based strategies for the prevention and management of CPSP at the system, hospital, and patient level. 一 Identify and discuss risk factors and screening approaches for the development of CPSP in pediatrics and adults, the co-development of screening measures for patients, and how the model can apply to other painful conditions.

New Brunswick


Democratizing Participant Engagement of Marginalized Communities in Chronic Pain Research: Crafting a Way Forward

Co-Chairs: D. Williams, A. Sud
Speakers: F. Webster, P. Rowland, L. Comer, D. Williams, A. Sud

LEARNING OBJECTIVES 一 Build knowledge and critical thinking around how social science can inform efforts to build equity, diversity, and inclusion as they pertain to PE in chronic pain research. 一 Recognize the importance of meaningfully engaging with communities who represent those who are members of historically marginalized groups. 一 Create conversation around how audience members can begin to enact EDI principles in relation to their own research.



From randomized trials to real world: How to mine the riches of healthcare databases for better pain research and surveillance.

Chair: A. Lacasse
Speakers: I. Gilron, L. Lix, A. Lacasse, H. Lore Nguena Nguefack

LEARNING OBJECTIVES 一 Summarize the merits and translational challenges of contemporary pain clinical trials. 一 Describe the added value of administrative healthcare databases for real-world evidence and initiatives to improve their access and use by researchers. 一 Identify various avenues to maximize the potential of administrative healthcare databases for pain research and provide examples of how such data can be used to better understand intra- and inter-individual variability in chronic pain treatment.



Where do we go from here? Exploring pain and mental health for youth with rheumatic diseases.

Chair: L. Proulx
Speakers: N. Trehan, N. Abrahams, M. Rafieinia, K. Toupin April, I. Dukes

LEARNING OBJECTIVES 一 Describe patient decision aids (PDAs) such as the JIA Option Map and describe the evidenced-based information to include in PDAs. 一 Identify the lived experience of pain of youth and young people living with rheumatic disease including mental health implications and how patient organizations can help address these needs and translate research evidence. 一 Demonstrate how research can help address the needs of youth and young people living with chronic pain and effectively engage patients throughout the research and clinical decision-making process (e.g. patient decision aids).



Exploring Placebo and Nocebo Effects in Pain Modulation: From rodents to humans.

Chair: J. Mogil
Speakers: G. Corder, J. Mogil, L. Colloca

LEARNING OBJECTIVES 一 Describe placebo/nocebo pain responses in rodents. 一 Identify neurobiological circuits related to placebo/nocebo pain modulation. 一 Define nocebo effects from a clinical and ethical perspective.

Les Saisons


Poster Session One


Refreshment Break

Browse posters and connect with our exhibitors.


Plenary ✸ Eliminating Anti-Indigenous Racism & Increasing the Cultural Safety of the Health System

Dr. Nel Wieman

Anti-Indigenous racism has been documented as widespread in BC’s health system and it plays a significant role in Indigenous patients accessing and receiving care for health conditions, including chronic pain and substance use. Clinicians, researchers and those in other health-related fields will benefit from learning how to develop cultural humility in their work that contributes to increased cultural safety. Trauma, historical and contemporary, is related to pain and addiction and learning how this impacts Indigenous patients is critical to increasing cultural safety. The BC Cultural Safety and Humility Standard is the first of its kind in Canada and plans are underway to create a national standard. Tools such as these can assist clinicians, researchers and others to develop a “two-eyed seeing” approach that will result in improved health outcomes for Indigenous people in Canada. LEARNING OBJECTIVES: 一 Describe what antiracism, cultural safety and cultural humility look like in their individual settings (clinical, research etc). 一 Identify how trauma is a major factor in pain & substance use for Indigenous (FN/M/I) people. 一 Integrate a “two-eyed seeing” approach into their individual settings (clinical, research etc).


Welcome and Opening Remarks